まとめ
タイロシンの利用可能性などの栄養学的要因は,脳のカテキオラミン合成に影響を与える可能性があります. この研究では,チロシン濃度がドーパ蓄積に直接影響を及ぼし,食事と神経伝達物質の産生との関連を示唆しています.
科学分野:
- 神経科学は神経科学である.
- バイオケミストリー バイオケミストリー
- 栄養科学とは,栄養科学である.
背景:
- ドーパミンなどのカタチョラミンは,重要な神経伝達物質である.
- カテコアミン合成の調節を理解することは,神経学的健康にとって不可欠です.
研究 の 目的:
- 脳のカテキオラミン合成の調節におけるチロシン利用の役割を調査する.
- 栄養学的介入が脳内のドーパ蓄積にどのように影響するかを決定する.
主な方法:
- デカルボキシラーゼ阻害後のドーパレベルを測定することによって,脳のカテキール合成を推定する.
- タイロシンおよび他の化合物 (トリプトファン,ルシン,パラクロロフェニララリン,フェニララリン) を投与して,脳タイロシン濃度を変化させる.
- これらの介入がドーパ蓄積率に与える影響を分析する.
主要な成果:
- タイロシン投与はドーパの蓄積を加速させ,カテキール合成の増加を示した.
- 脳タイロシン (トリプトファン,ルシン,パラクロロフェニララニン) を減少させる治療は,ドーパの蓄積を減少させた.
- 低用量のフェニララニンは脳チロシンを増加させたが,ドーパ合成を加速しなかった.
結論:
- 脳のカテキオラミン合成はチロシンの存在感に敏感である.
- 栄養学的および内分泌的要因は,前駆体アミノ酸のレベルを制御することによって,カテキオラミン合成を調節する可能性があります.
- これは,食事と脳機能と神経伝達物質の調節を結びつける潜在的なメカニズムを強調しています.
さらに関連する動画
関連する概念動画
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:29Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...